The Impact of the Covid-19 Pandemic on New and Ongoing Clinical Trials
Navigating the COVID-19 Pandemic, Preparing for the Rest of 2020 & Planning a Return to "Normalcy" in the New Clinical Trial Landscape

June 25 - 26, 2020 | Virtual Event

View Program

Vendor Registration

Free End User Registration

Meet the Speakers

View the event program for additional information on speakers, sessions, networking activities, and more!

Len Rosenberg PhD, RPh
Head, Clinical Operations
Beat AML/LLS

Leslie Jebson
Executive Director, Clinical Strategy
Texas A&M Health

Diane Maloney
Associate Director Policy, Center for Biologics Evaluation and Research (CBER)
Food and Drug Administration (FDA)

Rose Gerber
Director of Patient Advocacy and Education
Community Oncology Alliance (COA)

Jennifer Healey
Head of Global Medical Operations
Sanofi

Jeff Douglas
Head of Clinical Operations
MyoKardia

Craig Lipset
Fmr. Head of Clinical Innovation
Pfizer

Steffen Thirstrup MD, PhD
Fmr. Head of Division, Medicines Assessment and Clinical Trials
Danish Health and Medicines Authority

Heiner Gertzen
Head GxP Inspection & Audit Readiness
Sanofi

Tim Hagerty
VP Development & Business Operations
Dantari

QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com